1
|
The Work and Social Adjustment Scale: a simple measure of impairment in functioning.
|
Br J Psychiatry
|
2002
|
6.02
|
2
|
Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial.
|
Psychother Psychosom
|
2002
|
1.94
|
3
|
Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology.
|
J Psychiatr Res
|
2010
|
1.43
|
4
|
Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology.
|
J Clin Psychiatry
|
2007
|
1.06
|
5
|
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
|
Curr Med Res Opin
|
2007
|
1.04
|
6
|
Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the electronic Columbia-Suicide Severity Rating Scale.
|
J Clin Psychiatry
|
2013
|
1.01
|
7
|
A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
|
Int Clin Psychopharmacol
|
2012
|
0.94
|
8
|
Is it easier to find what you are looking for if you think you know what it looks like?
|
J Clin Psychopharmacol
|
2007
|
0.94
|
9
|
Validation of an IVRS version of the MADRS.
|
J Psychiatr Res
|
2005
|
0.92
|
10
|
Telephonic Remote Evaluation of Neuropsychological Deficits (TREND): longitudinal monitoring of elderly community-dwelling volunteers using touch-tone telephones.
|
Alzheimer Dis Assoc Disord
|
2007
|
0.91
|
11
|
An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trials.
|
J Clin Psychopharmacol
|
2006
|
0.90
|
12
|
A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology.
|
J Clin Psychiatry
|
2007
|
0.89
|
13
|
The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
|
J Clin Psychiatry
|
2006
|
0.89
|
14
|
A comparison of initial duloxetine dosing strategies in patients with major depressive disorder.
|
J Clin Psychiatry
|
2007
|
0.86
|
15
|
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
|
J Clin Psychiatry
|
2003
|
0.83
|
16
|
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
|
Int Clin Psychopharmacol
|
2005
|
0.82
|
17
|
A novel interactive voice response (IVR) system for dementia screening, education, and referral: one-year summary.
|
Alzheimer Dis Assoc Disord
|
2005
|
0.81
|
18
|
WCA recommendations for the long-term treatment of panic disorder.
|
CNS Spectr
|
2003
|
0.80
|
19
|
Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study.
|
J Clin Psychopharmacol
|
2002
|
0.79
|
20
|
Cost-effectiveness of computer-aided behaviour therapy for obsessive-compulsive disorder.
|
Psychother Psychosom
|
2007
|
0.79
|
21
|
Using daily interactive voice response assessments: to measure onset of symptom improvement with duloxetine.
|
Psychiatry (Edgmont)
|
2007
|
0.79
|
22
|
Voice response system to measure healthcare costs: a STAR*D report.
|
Am J Manag Care
|
2009
|
0.78
|
23
|
Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET).
|
Psychiatry (Edgmont)
|
2007
|
0.78
|
24
|
A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.
|
J Clin Psychiatry
|
2008
|
0.78
|
25
|
Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study.
|
Prim Care Companion J Clin Psychiatry
|
2007
|
0.75
|
26
|
Assessing onset of treatment benefit in depression and anxiety: conceptual considerations.
|
J Clin Psychiatry
|
2009
|
0.75
|
27
|
WCA recommendations for the long-term treatment of social phobia.
|
CNS Spectr
|
2003
|
0.75
|
28
|
Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies.
|
Int Clin Psychopharmacol
|
2013
|
0.75
|
29
|
Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.
|
Ann Clin Psychiatry
|
2006
|
0.75
|